'Pfizer Biontech' - 156 News Result(s)
- World News | Agence France-Presse | Thursday November 3, 2022Pfizer-BioNTech said Thursday they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses.
www.ndtv.com
- World News | Agence France-Presse | Friday August 26, 2022Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their shot for COVID-19.
www.ndtv.com
- World News | Agence France-Presse | Wednesday June 15, 2022Europe's medicines watchdog said Wednesday it has started to review an adapted version of Pfizer/BioNTech's anti-Covid jab in order to better protect against specific variants of the virus, including Omicron.
www.ndtv.com
- World News | Agence France-Presse | Thursday April 14, 2022Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
www.ndtv.com
- World News | Agence France-Presse | Wednesday March 16, 2022Pfizer and BioNTech announced Tuesday they had formally asked the United States drug regulator for emergency approval of a second booster shot of their Covid vaccine for people aged 65 and older.
www.ndtv.com
- World News | Agence France-Presse | Wednesday February 2, 2022Pfizer and BioNTech will soon ask US regulators for emergency authorization for a Covid-19 vaccine for children aged five and under, US media reported Tuesday.
www.ndtv.com
- World News | Agence France-Presse | Tuesday January 25, 2022Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday.
www.ndtv.com
- World News | Janice Kew and Antony Sguazzin, Bloomberg | Thursday December 16, 2021A two-dose course of Pfizer Inc. and BioNTech SE's Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists from the Africa Health Research Institute in South Africa said.
www.ndtv.com
- World News | Jason Gale and Naomi Kresge, Bloomberg | Thursday December 9, 2021The earliest studies on omicron are in and the glimpse they're providing is cautiously optimistic: while vaccines like the one made by Pfizer Inc. and BioNTech SE may be less powerful against the new variant, protection can be fortified with boosters
www.ndtv.com
- World News | Naomi Kresge, Robert Langreth and Riley Griffin, Bloomberg | Thursday December 9, 2021Pfizer Inc. and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world and may lead to use of new strain-spec
www.ndtv.com
- World News | Naomi Kresge, Bloomberg | Thursday December 9, 2021Pfizer and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world.
www.ndtv.com
- World News | Agence France-Presse | Thursday December 9, 2021Two doses of the BioNTech and Pfizer coronavirus vaccine may not be enough to protect against the Omicron variant, the companies warned Wednesday, but stressed it was "still effective" after a third jab.
www.ndtv.com
- World News | Agence France-Presse | Wednesday December 1, 2021The EU's main Covid vaccine provider, BioNTech/Pfizer, will have jabs available for children in the bloc in two weeks' time, European Commission chief Ursula von der Leyen said Wednesday.
www.ndtv.com
- World News | Agence France-Presse | Friday November 26, 2021Germany's BioNTech said Friday it was urgently studying how well the coronavirus vaccine it developed with Pfizer protects against the new B.1.1.529 variant detected in South Africa.
www.ndtv.com
- World News | Agence France-Presse | Wednesday November 24, 2021Pfizer and BioNTech said Monday their COVID-19 vaccine remained 100 percent effective in children 12 to 15 years old, four months after the second dose.
www.ndtv.com
'Pfizer Biontech' - 17 Video Result(s)
'Pfizer Biontech' - 156 News Result(s)
- World News | Agence France-Presse | Thursday November 3, 2022Pfizer-BioNTech said Thursday they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses.
www.ndtv.com
- World News | Agence France-Presse | Friday August 26, 2022Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their shot for COVID-19.
www.ndtv.com
- World News | Agence France-Presse | Wednesday June 15, 2022Europe's medicines watchdog said Wednesday it has started to review an adapted version of Pfizer/BioNTech's anti-Covid jab in order to better protect against specific variants of the virus, including Omicron.
www.ndtv.com
- World News | Agence France-Presse | Thursday April 14, 2022Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
www.ndtv.com
- World News | Agence France-Presse | Wednesday March 16, 2022Pfizer and BioNTech announced Tuesday they had formally asked the United States drug regulator for emergency approval of a second booster shot of their Covid vaccine for people aged 65 and older.
www.ndtv.com
- World News | Agence France-Presse | Wednesday February 2, 2022Pfizer and BioNTech will soon ask US regulators for emergency authorization for a Covid-19 vaccine for children aged five and under, US media reported Tuesday.
www.ndtv.com
- World News | Agence France-Presse | Tuesday January 25, 2022Pfizer and BioNTech have begun enrollment for a clinical trial to test the safety and immune response of their Omicron-specific Covid-19 vaccine in adults aged up to 55, the companies said in a statement Tuesday.
www.ndtv.com
- World News | Janice Kew and Antony Sguazzin, Bloomberg | Thursday December 16, 2021A two-dose course of Pfizer Inc. and BioNTech SE's Covid-19 shot as well as a previous infection with the disease may give stronger protection against the omicron variant, scientists from the Africa Health Research Institute in South Africa said.
www.ndtv.com
- World News | Jason Gale and Naomi Kresge, Bloomberg | Thursday December 9, 2021The earliest studies on omicron are in and the glimpse they're providing is cautiously optimistic: while vaccines like the one made by Pfizer Inc. and BioNTech SE may be less powerful against the new variant, protection can be fortified with boosters
www.ndtv.com
- World News | Naomi Kresge, Robert Langreth and Riley Griffin, Bloomberg | Thursday December 9, 2021Pfizer Inc. and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world and may lead to use of new strain-spec
www.ndtv.com
- World News | Naomi Kresge, Bloomberg | Thursday December 9, 2021Pfizer and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world.
www.ndtv.com
- World News | Agence France-Presse | Thursday December 9, 2021Two doses of the BioNTech and Pfizer coronavirus vaccine may not be enough to protect against the Omicron variant, the companies warned Wednesday, but stressed it was "still effective" after a third jab.
www.ndtv.com
- World News | Agence France-Presse | Wednesday December 1, 2021The EU's main Covid vaccine provider, BioNTech/Pfizer, will have jabs available for children in the bloc in two weeks' time, European Commission chief Ursula von der Leyen said Wednesday.
www.ndtv.com
- World News | Agence France-Presse | Friday November 26, 2021Germany's BioNTech said Friday it was urgently studying how well the coronavirus vaccine it developed with Pfizer protects against the new B.1.1.529 variant detected in South Africa.
www.ndtv.com
- World News | Agence France-Presse | Wednesday November 24, 2021Pfizer and BioNTech said Monday their COVID-19 vaccine remained 100 percent effective in children 12 to 15 years old, four months after the second dose.
www.ndtv.com